Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2Y2nT1G
via IFTTT